As of 2024-12-15, the Relative Valuation of AnaptysBio Inc (ANAB) is (97.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.59 USD, the upside of AnaptysBio Inc based on Relative Valuation is -726.8%.
The range of the Relative Valuation is (85.80) - (107.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 20.7x | 17.0x |
| Forward P/E multiples | 15.8x - 19.7x | 19.0x |
| Fair Price | (85.80) - (107.35) | (97.72) |
| Upside | -650.3% - -788.6% | -726.8% |
| Date | P/E |
| 2024-11-20 | -3.73 |
| 2024-11-19 | -3.67 |
| 2024-11-18 | -3.47 |
| 2024-11-15 | -3.49 |
| 2024-11-14 | -3.71 |
| 2024-11-13 | -3.81 |
| 2024-11-12 | -3.95 |
| 2024-11-11 | -4.11 |
| 2024-11-08 | -3.91 |
| 2024-11-07 | -3.95 |
| 2024-11-06 | -4.08 |
| 2024-11-05 | -3.65 |
| 2024-11-04 | -3.66 |
| 2024-11-01 | -3.98 |
| 2024-10-31 | -3.97 |
| 2024-10-30 | -4.07 |
| 2024-10-29 | -5.66 |
| 2024-10-28 | -5.60 |
| 2024-10-25 | -5.88 |
| 2024-10-24 | -5.92 |
| 2024-10-23 | -6.38 |
| 2024-10-22 | -6.46 |
| 2024-10-21 | -6.50 |
| 2024-10-18 | -6.43 |
| 2024-10-17 | -6.46 |
| 2024-10-16 | -6.37 |
| 2024-10-15 | -6.11 |
| 2024-10-14 | -6.38 |
| 2024-10-11 | -6.10 |
| 2024-10-10 | -5.88 |
| 2024-10-09 | -5.77 |
| 2024-10-08 | -5.94 |
| 2024-10-07 | -6.06 |
| 2024-10-04 | -6.24 |
| 2024-10-03 | -6.43 |
| 2024-10-02 | -6.43 |
| 2024-10-01 | -6.39 |
| 2024-09-30 | -6.15 |
| 2024-09-27 | -5.85 |
| 2024-09-26 | -5.97 |
| 2024-09-25 | -5.94 |
| 2024-09-24 | -6.41 |
| 2024-09-23 | -6.53 |
| 2024-09-20 | -7.07 |
| 2024-09-19 | -6.89 |
| 2024-09-18 | -6.72 |
| 2024-09-17 | -6.89 |
| 2024-09-16 | -7.11 |
| 2024-09-13 | -7.41 |
| 2024-09-12 | -7.04 |